Adding to growing evidence that the novel coronavirus can spread through air, scientists have identified genetic markers of the virus in airborne droplets, many with diameters smaller than one-ten-thousandth of an inch. That had been previ

What is big data? What is Bioprocess 4.0? How do you leverage data to make

Teva has won a ruling that could keep its cancer drug Bendeka free from generic competition for more than a decade. A federal judge in Delaware this week ruled that proposed generic versions of Bendeka by Mylan, Fresenius Kabi, Apotex and

Biopharma ScieGen is expanding its manufacturing operations on Long Island and adding over 100 jobs. The $15 million expansion will help ScieGen, a subsidiary of Bactolac Pharmaceutical, bolster its production of prescription drugs to meet

A U.S. Patent for a "Method for Increasing the Glutathione Level in Cells" was awarded to Merck KGaA on April 21st, 2020. The present invention is a method for increasing the level of glutathione in m

A U.S. Patent for a "Method of Protein Manufacture" was awarded to UCB Biopharma on April 21st, 2020. The present invention is a method for manufacturing an antigen-binding fragment of an antibody cou

Catalent has completed a $14 million expansion to increase its biologics packaging capabilities and capacity at its Bloomington, IN facility. The expansion adds 15,000 square feet of packaging infrastructure to the biologics and sterile ma

A group of Chinese scientists report the isolation of two human monoclonal antibodies with the potential to treat and to prevent SARS-CoV-2 infections, the causative agent of COVID-19. The work is described in a manuscript made available b

The MHRA has relaxed its interpretation of good manufacturing practices (GMPs) in light of challenges created by the COVID-19 pandemic. MHRA's more flexible approach to GMPs is intended to achieve two goals. Firstly, MHRA hopes to free up

Researchers at MIT; the Ragon Institute of MGH, MIT, and Harvard; and the Broad Institute of MIT and Harvard; along with colleagues from around the world have identified specific types of cells that appear to be targets of the coronavirus

Updated April 22nd, 2020 with new information on vaccines from Moderna, University of Oxford, Inovio, BioNTech, Sinovac and Novavax; the addition of new candidates from University of Waterloo and University of Georgia; and updates to precl

A U.S. Patent Application for "Selective Reduction of Proteins" was published by Seattle Genetics on April 16th, 2020. The present invention provides a method for making uncapped cysteine protein prep